Christopher D. Abraham

Christopher D. Abraham, MD is an Associate Professor of Radiation Oncology and Associate Professor of Medicine at Washington University School of Medicine in St. Louis. He is affiliated with the Siteman Cancer Center, Brain Tumor Center, and Institute of Clinical and Translational Sciences (ICTS). Dr. Abraham practices at multiple locations including the Center for Advanced Medicine Radiation Oncology Center, Barnes-Jewish West County Hospital, and Siteman Cancer Center – North County. His clinical work focuses on radiation oncology with expertise in treating brain tumors and other cancers.

Dr. Abraham completed his Medical Degree at Saint Louis University School of Medicine in 2011 and his Residency in Radiation Oncology at Barnes-Jewish Hospital and Washington University School of Medicine in 2016. He earned his BS in Radiologic Science from the Medical College of Georgia in 2004.

Dr. Abraham's research focuses on advancing radiation therapy techniques, particularly in stereotactic radiosurgery for brain metastases, hippocampal-avoidance whole brain radiation therapy, and innovative approaches for glioblastoma treatment. His work demonstrates a strong emphasis on optimizing radiation delivery while minimizing neurocognitive side effects. He has pioneered simulation-free radiation therapy techniques that expedite treatment planning, particularly for palliative care patients. His research also explores the integration of AI and large language models in radiation oncology workflows and insurance appeals processes.

Analysis of Dr. Abraham's recent publications reveals a clear research trajectory focused on improving precision in radiation therapy for brain tumors, with particular attention to hippocampal protection, adaptive planning techniques, and combined modality approaches. His work spans clinical trials, technical innovations in treatment planning, and translational research connecting imaging with treatment outcomes. The increasing citation counts of his work, particularly his 2023 paper on simulation-free radiation therapy which has 34 citations, demonstrates growing impact in the field.

While specific awards are not listed in the provided information, Dr. Abraham's work has accumulated 536 citations according to Scopus metrics, indicating significant scholarly impact. His research has been referenced in clinical guidelines and policy sources, demonstrating translational relevance to clinical practice.

Dr. Abraham actively collaborates with multidisciplinary teams including neurosurgeons, medical oncologists, and physicists. His work on the NRG Oncology/RTOG 0631 trial demonstrates involvement in large cooperative group studies. He has contributed to efforts examining insurance policy adherence to radiation oncology guidelines, showing engagement with healthcare systems issues.

As a key member of the Brain Tumor Center at Siteman Cancer Center, Dr. Abraham participates in comprehensive brain tumor care teams that integrate surgical, medical, and radiation oncology approaches. His work with the Institute of Clinical and Translational Sciences highlights his commitment to translating research findings into clinical practice. Current research directions include exploring simulation-free radiation therapy techniques, optimizing hippocampal-sparing approaches, and investigating novel combinations of radiation with immunotherapies.